Cephalothin Sodium

   
Google
 
Web NewDrugInformation.com

Cephalothin Sodium


Drug - Cephalothin Sodium
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Cephalothin Sodium
Multiple ingredients are in alphabetical order.

Strength - EQ 2GM BASE/VIAL
The potency of the active ingredient(s), Cephalothin Sodium. May repeat for multiple part products.

Applicant - BRISTOL
The firm name holding legal responsibility for Cephalothin Sodium. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 062464
The FDA assigned number to Cephalothin Sodium. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Cephalothin Sodium. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 7, 1984
The date Cephalothin Sodium was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Cephalothin Sodium. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Cephalothin Sodium is in. Format is RX, OTC, DISCN.

Applicant Full Name - Bristol Laboratories Inc Div Bristol Myers Co
The full name of the firm holding legal responsibility for the new application of Cephalothin Sodium.

Cephalothin Sodium